Nanotechnology for therapy and imaging of liver diseases

Journal of Hepatology

Volumn 55, Issue 6, 2011, Pages 1461-1466

  Reddy, L Harivardhan ^a   Couvreur, Patrick ^b  

^a SANOFI   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; ANTILEISHMANIAL AGENT; ATOVAQUONE; BCG VACCINE; DEXAMETHASONE; DOXORUBICIN; GADOLINIUM; HARMINE; INTERFERON ALPHA1B; LIPOSOME; MELATONIN; MILTEFOSINE; MITOXANTRONE; NANOPARTICLE; PEGINTERFERON ALPHA; QUERCETIN; RIBAVIRIN; SMALL INTERFERING RNA; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; THERMODOX; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; ALLERGIC REACTION; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; DRUG TREATMENT FAILURE; FIBROGENESIS; GENE DELIVERY SYSTEM; GENE TARGETING; HEPATITIS; HEPATITIS B; HUMAN; HYPOKALEMIA; HYPOTENSION; KUPFFER CELL; LEISHMANIASIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; MACROPHAGE; NANOTECHNOLOGY; NEPHROTOXICITY; NEUTROPENIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRIORITY JOURNAL; REPORTER GENE; SALMONELLOSIS;

EID: 81355149640     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.05.039     Document Type: Note

References (34)

1. F. Li, and J.-y. Wang Targeted delivery of drugs for liver fibrosis Expert Opin Drug Deliv 6 2009 531 541
2. C.R. Alving Delivery of liposome-encapsulated drugs to macrophages Pharmac Ther 22 1983 407 424
3. P. Couvreur, and C. Vauthier Nanotechnology: intelligent design to treat complex disease Pharm Res 23 2006 1417 1450
4. T. Knittel, D. Kobold, B. Saile, A. Grundmann, K. Neubauer, and F. Piscaglia Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential Gastroenterology 117 1999 1205 1221
5. L. Beljaars, P. Olinga, G. Molema, P. de Bleser, A. Geerts, and G.M.M. Groothuis Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P28-HSA) Liver 21 2001 320 328
6. J.E. Adrian, J.A. Kamps, K. Poelstra, G.L. Scherphof, D.K. Meijer, and Y. Kaneda Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes J Drug Target 15 2007 75 82
7. L. Beljaars, G. Molema, D. Schuppan, A. Geerts, P.J. De Bleser, and B. Weert Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor J Biol Chem 275 2000 12743 12751
8. S.-L. Du, H. Pan, W.-Y. Lu, J. Wang, J. Wu, and J.-Y. Wang Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats J Pharmacol Exp Ther 322 2007 560 568
9. Y. Sato, K. Murase, J. Kato, M. Kobune, T. Sato, and Y. Kawano Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone Nat Biotechnol 26 2008 431 442
10. A.K. Mandal, S. Das, Basu.M.K. Chakrabarti, and Das.N. RN Hepatoprotective activity of liposomal flavonoid against arsenite-induced liver fibrosis J Pharmacol Exp Ther 320 2007 994 1001
11. B.N. Melgert, P. Olinga, V.K. Jack, G. Molema, D.K.F. Meijer, and K. Poelstra Dexamethasone coupled to albumin is selectively taken up by rat nonparenchymal liver cells and attenuates LPS-induced activation of hepatic cells J Hepatol 32 2000 603 611
12. H. Wang, W. Wei, S.-Y. Zhang, Y.-X. Shen, L. Yue, and N.-P. Wang Melatonin-selenium nanoparticles inhibit oxidative stress and protect against hepatic injury induced by Bacillus Calmette-Guerin/lipopolysaccharide in mice J Pineal Res 39 2005 156 163
13. J. Wu, L. Liu, R.D. Yen, A. Catana, M.H. Nantz, and M.A. Zern Liposome-mediated extracellular superoxide dismutase gene delivery protects against acute liver injury in mice Hepatology 40 2004 195 204
14. G.-F. Wang, L.-P. Shi, and J.-P. Zuo Anti-hepatitis B virus drugs in clinical and preclinical development Virol Sin 23 2008 137 145
15. J. Jung, T. Matsuzaki, K. Tatematsu, T. Okajima, K. Tanizawa, and S. Kuroda Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials J Control Rel 126 2008 255 264
16. M. Feng, Q. Cai, H. Huang, and P. Zhou Liver targeting and anti-HBV activity of reconstituted HDL-acyclovir palmitate complex Eur J Pharm Biopharm 68 2008 688 693
17. S. Carmona, M.R. Jorgensen, S. Kolli, C. Crowther, F.H. Salazar, and P.L. Marion Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles Mol Pharm 6 2009 706 717
18. D.V. Morrissey, J.A. Lockridge, L. Shaw, K. Blanchard, K. Jensen, and W. Breen Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs Nat Biotechnol 23 2005 1002 1007
19. C.R. Alving, E.A. Steck, W.L. Chapman Jr. , V.B. Waits, L.D. Hendrick, and G.M. Swartz Jr. Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs Proc Nat Acad Sci USA 75 1978 2959 2963
20. M.D. Moen, K.A. Lyseng-Williamson, and L.J. Scott Liposomal Amphotericin B a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections Drugs 69 2009 361 392
21. E. Fattal, M. Youssef, P. Couvreur, and A. Andremont Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles Antimicrob Agents Chemother 33 1989 1540 1543
22. M.B. Thomas, D. Jaffe, M.M. Choti, J. Belghiti, S. Curley, and Y. Fong Hepatocellular Carcinoma: consensus recommendations of the national cancer institute clinical trials planning meeting J Clin Oncol 28 2010 3994 4005
23. L. Barraud, P. Merle, E. Soma, L. Lefrancois, S. Guerret, and M. Chevallier Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo J Hepatol 42 2005 736 743
24. Merle P, Si Ahmed S, Habersetzer F, Abergel A, Taieb J, Bonyhay L, et al. Phase 1 study of intra-arterial hepatic (IAH) delivery of doxorubicin-transdrug (DT) for patients with advanced hepatocellular carcinoma (HCC). J Clin Oncol 2006 [ASCO annual meeting proceedings Part I. 2006; 24, No. 18S: (June 20 Supplement): 14094].
25. Doxorubicin Transdrug®: significant increased survival rate in patients with advanced hepatocellular carcinoma treated in a phase II clinical trial. Bioalliance web document 2009; 8 Dec.
26. Q. Zhou, X. Sun, L. Zeng, J. Liu, and Z. Zhang A randomized multicenter phase II clinical trial of mitoxantrone-loaded nanoparticles in the treatment of 108 patients with unresected hepatocellular carcinoma Nanomed Nanotech Biol Med 5 2009 419 423
27. G. Kong, G. Anyarambhatla, W.P. Petros, R.D. Braun, O.M. Colvin, and D. Needham Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release Cancer Res 60 2000 6950 6957
28. D. Lorusso, A. Di Stefano, V. Carone, A. Fagotti, S. Pisconti, and G. Scambia Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome) Ann Oncol 18 2007 1159 1164
29. F.-R. Li, W.-H. Yan, Y.-H. Guo, H. Qi, and H.-X. Zhou Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer Int J Hyperthermia 25 2009 383 391
30. N.K. Jain, and S.K. Jain Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin AAPS PharmSciTech 11 2010 686 697
31. J. Yano, K. Hirabayashi, S. Nakagawa, T. Yamaguchi, M. Nogawa, and I. Kashimori Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer Clin Cancer Res 10 2004 7721 7726
32. S.R. Digumarthy, D.V. Sahani, and S. Saini MRI in detection of hepatocellular carcinoma (HCC) Cancer Imaging 5 2005 20 24
33. A. Tanimoto, and S. Kuribayashi Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma Eur J Radiol 58 2006 200 216
34. J.L. Arias, L.H. Reddy, M. Othman, B. Gillet, D. Desmaele, and F. Zouhiri Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics ACS Nano 5 2011 1513 1521